Free from Publisher

Quantitative 68Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with …

C Ortega, RKS Wong, J Schaefferkoetter… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The aim of this study was to determine whether quantitative PET parameters on baseline
68Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …
被引用次数：66 相关文章

Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated …

C Ortega, RKS Wong… - Journal of nuclear …, 2021 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to determine whether quantitative PET parameters on baseline 68
Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …
[PDF] researchgate.net

[PDF][PDF] Quantitative 68 Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors …

C Ortega, RKS Wong, J Schaefferkoetter… - THE JOURNAL OF …, 2021 - researchgate.net
The aim of this study was to determine whether quantitative PET parameters on baseline
68Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …

Quantitative 68 Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated …

C Ortega, RKS Wong, J Schaefferkoetter… - Journal of Nuclear …, 2021 - europepmc.org
The aim of this study was to determine whether quantitative PET parameters on baseline
68Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …

[引用][C] Quantitative 68 Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors …

C Ortega, RKS Wong, J Schaefferkoetter… - Journal of Nuclear …, 2021 - cir.nii.ac.jp
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy
Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated with …

Quantitative 68Ga-Dotatate PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with …

C Ortega, RKS Wong, J Schaefferkoetter… - Journal of Nuclear …, 2021 - cris.bgu.ac.il
PURPOSE: To determine whether quantitative PET parameters on baseline 68 Ga-
DOTATATE PET/CT (bPET) and interim PET (iPET) performed prior to second cycle of …
[PDF] snmjournals.org

[PDF][PDF] Quantitative 68 Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors …

C Ortega, RKS Wong, J Schaefferkoetter… - THE JOURNAL OF …, 2021 - Soc Nuclear Med
The aim of this study was to determine whether quantitative PET parameters on baseline
68Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …
[HTML] nih.gov

[HTML][HTML] Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors …

C Ortega, RKS Wong, J Schaefferkoetter… - Journal of Nuclear …, 2021 - ncbi.nlm.nih.gov
The aim of this study was to determine whether quantitative PET parameters on baseline 68
Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …

Quantitative 68Ga-DOTATATE PET/CT Parameters for the Prediction of Therapy Response in Patients with Progressive Metastatic Neuroendocrine Tumors Treated …

C Ortega, RKS Wong… - Journal of nuclear …, 2021 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to determine whether quantitative PET parameters on baseline 68
Ga-DOTATATE PET/CT and interim PET (iPET) performed before the second cycle of …